Drug information for PERMAX

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET; ORAL EQ 0.05MG BASE Discontinued   PERGOLIDE MESYLATE Pergolide VALEANT PHARM INTL 19385
2009-01-12 Review

2009-01-12 Review

2007-03-29 Other Important Information from FDA

2003-10-10 Label

2003-10-10 Label

2003-10-10 Label

2003-10-09 Letter

2003-10-09 Letter

2003-10-09 Letter

2002-08-29 Letter
TABLET; ORAL EQ 0.25MG BASE Discontinued   PERGOLIDE MESYLATE Pergolide VALEANT PHARM INTL   "
TABLET; ORAL EQ 1MG BASE Discontinued   PERGOLIDE MESYLATE Pergolide VALEANT PHARM INTL   "

Drug Adverse Effects information for PERMAX

Role code Indications Reaction # Reports
C PARKINSON'S DISEASE ALOPECIA 4
C PARKINSON'S DISEASE COMPLETED SUICIDE 2
C PARKINSON'S DISEASE DELUSION 4
C PARKINSON'S DISEASE HALLUCINATION, AUDITORY 4
C PARKINSON'S DISEASE HALLUCINATION, VISUAL 4
C PARKINSON'S DISEASE PENILE SIZE REDUCED 4
Ads by Google